operation11. Until Can meaningful conclusions be drawn from six trials with such disparate results? The wide variation in outcomes between these trials suggests several explanations: patients in different trials were dissimiliar; endoscopic sclerotherapy was performed more effectively in some trials; or the titration of propranolol and/or compliance with taking the drug was better in some trials.
The latter seems least likely since all of the trials treated patients with proprano1ol to reduce resting pulse rates from 20 to 25% and compliance with taking the drug was good. On the other hand, entry criteria, sclerotherapy technique, and sclerotherapy treatment intervals varied widely across these studies. The majority of patients in the five previously published trials had alcohol induced cirrhosis in Table 1 Results of six prospective randomized trials which compared serial sclerotherapy with propranolol for prevention of recurrent bleeding from esophageal varices. S=sclerotherapy, P propranolol, % Rebled proportion of patients who experienced one or more episodes of recurrent hemorrhage from esophagael varices, % Child C total proportion of Child-Pugh class C patients in both arms of trial, % EtOH proportion of alcoholic cirrhotics in both arms of trial (*p>0.05) 
